Global Regenerative Medicine Market - Segmented by Type of Products, Therapy and Applications - Growth, Trends and Forecasts (2018 - 2023)

  • ID: 4472666
  • Report
  • Region: Global
  • 113 pages
  • Mordor Intelligence
UP TO OFF
until Dec 31st 2018
1 of 5

FEATURED COMPANIES

  • ACELITY
  • ASTRAZENECA
  • COOK BIOTECH INCORPORATED
  • MERCK & CO
  • ORGANOGENESIS INC.
  • OSIRISTHERAPEUTICS Inc.
  • MORE
The global regenerative medicine market has been estimated to reach USD 4.23 billion in 2023. The market is expected to register a CAGR of 14% during the forecast period 2018 to 2023. North America dominates the market due to the increasing technological advancements.

Increasing adoption of stem cell technology

Increasing adoption of stem cell technology, increasing prevalence of chronic diseases, emerging applications of gene therapy in regenerative medicine are some of the driving factors for Global Regenerative Medicine market. Technological advances in regenerative medicine (stem cell, tissue engineering, and nanotechnology) and high investment & funding to support development of regenerative medicine are also fuelling the market growth.

Regulatory and ethical issues

Regulatory and ethical issues pertaining stem cell, tissues engineering and regenerative medicine are acting as a restraint for Regenerative Medicine market. High cost of treatments and less awareness about the regenerative medicine among people is further restraining the market.

North America to Dominate the Market

The Regenerative Medicine market is segmented by type of treatment and geography. By geography it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America.

North America dominates the Regenerative Medicine market due to the increasing technological advancements and high investment & funding to support development of regenerative medicine. Asia-Pacific is also expected to propel the Regenerative Medicine market owing to factors, such as increasing accessibility to healthcare facilities in the region, and increasing economic growth.

Key Developments in the Market
  • In January, 2018: Medeor Therapeutics Awarded $18.8 Million From the California Institute for Regenerative Medicine
  • In January, 2018: RepliCel Life Sciences Inc. formed a partnership with the private firm, China-based Yofoto Health Industry Co. Ltd for regenerative medicine
Major key players: ACELITY, OSIRIS THERAPEUTICS, INC., INTEGRA LIFESCIENCES CORPORATION, ASTRAZENECA, COOK BIOTECH INCORPORATED, ORGANOGENESIS INC. and MERCK & CO., INC. etc.

Reasons to Purchase this Report
  • Market analysis for the Global Regenerative Medicine Market, with region-specific assessments and competition analysis on a global and regional scale.
  • Analyzing various perspectives of the company with the help of Porter’s five forces analysis
  • The treatment type that is expected to dominate the market
  • Regions that are expected to witness fastest growth during the forecast period
  • Identify the latest developments, market shares and strategies employed by the major market players.
  • 3 months analyst support along with the Market Estimate sheet in excel.
Customization of the Report

This report can be customized to meet your requirements..
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • ACELITY
  • ASTRAZENECA
  • COOK BIOTECH INCORPORATED
  • MERCK & CO
  • ORGANOGENESIS INC.
  • OSIRISTHERAPEUTICS Inc.
  • MORE
1. INTRODUCTION
1.1 MARKET DEFINITION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. KEY INFERENCES

5. MARKET OVERVIEW
5.1 CURRENT MARKET SCENARIO
5.2 PORTER’S FIVE FORCES
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF CONSUMERS
5.2.3 THREATS OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTE PRODUCT AND SERVICES
5.2.5 COMPETITIVE RIVALRY WITHIN THE INDUSTRY

6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 MARKET DRIVERS
6.1.1 INCREASING ADOPTION OF STEM CELL TECHNOLOGY
6.1.2 TECHNOLOGICAL ADVANCES IN REGENERATIVE MEDICINE
6.2 MARKET RESTRAINTS
6.2.1 REGULATORY AND ETHICAL ISSUES
6.2.2 HIGH COST OF TREATMENTS AND LESS AWARENESS
6.3 OPPORTUNITIES
6.4 KEY CHALLENGES

7. MARKET SEGMENTATION
7.1 BY TYPE OF TECHNOLOGY
7.1.1 STEM CELL THERAPY
7.1.2 BIOMATERIAL
7.1.3 TISSUE ENGINEERING
7.2 BY TYPE OF APPLICATIONS
7.2.1 BONE GRAFT SUBSTITUTES
7.2.2 OSTEOARTICULAR DISEASES
7.2.3 DERMATOLOGY
7.2.4 CARDIOVASCULAR
7.2.5 CENTRAL NERVOUS SYSTEM
7.3 BY GEOGRAPHY
7.3.1 NORTH AMERICA
7.3.1.1 US
7.3.1.2 CANADA
7.3.1.3 MEXICO
7.3.2 EUROPE
7.3.2.1 FRANCE
7.3.2.2 UK
7.3.2.3 GERMANY
7.3.2.4 ITALY
7.3.2.5 SPAIN
7.3.2.6 REST OF EUROPE
7.3.3 ASIA-PACIFIC
7.3.3.1 INDIA
7.3.3.2 CHINA
7.3.3.3 JAPAN
7.3.3.4 AUSTRALIA
7.3.3.5 SOUTH KOREA
7.3.3.6 REST OF APAC
7.3.4 MIDDLE EAST AND AFRICA
7.3.4.1 GCC
7.3.4.2 SOUTH AFRICA
7.3.4.3 REST OF MIDDLE EAST AND AFRICA
7.3.5 SOUTH AMERICA
7.3.5.1 BRAZIL
7.3.5.2 ARGENTINA
7.3.5.3 REST OF SOUTH AMERICA

8. COMPETITIVE LANDSCAPE
8.1 MERGERS AND ACQUISITIONS
8.2 AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS
8.3 NEW PRODUCT LAUNCHES

9. KEY PLAYERS
9.1 ACELITY
9.2 OSIRIS THERAPEUTICS
9.3 INTEGRA LIFESCIENCES CORPORATION
9.4 COOK BIOTECH INCORPORATED
9.5 ORGANOGENESIS INC
9.6 MERCK & CO
9.7 OTHERS

10. FUTURE OUTLOOK OF THE MARKET
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • ACELITY
  • OSIRISTHERAPEUTICS Inc.
  • INTEGRA LIFESCIENCES CORPORATION
  • ASTRAZENECA
  • COOK BIOTECH INCORPORATED
  • ORGANOGENESIS INC.
  • MERCK & CO
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll